Table 2. Univariate and multivariate Cox proportional hazards regression analysis.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | |
Risk scorea | 2.718 (2.103–3.514) | 2.32E−14 | 2.513 (1.886–3.348) | 3.12E−10 |
Age | 1.01 (0.997–1.024) | 0.139 | 1.009 (0.993–1.025) | 0.2602 |
Gender (Male/Female) | 0.816 (0.573–1.163) | 0.26 | 0.968 (0.646–1.450) | 0.8748 |
TP53 mutation (Y/N) | 1.563 (1.078–2.266) | 0.0184 | 1.395 (0.915–2.128) | 0.1217 |
HBV infection (Y/N) | 1.697 (1.199–2.402) | 0.0029 | 1.656 (1.113–2.463) | 0.0129 |
Pathologic stage (ii/i) | 1.423 (0.872–2.323) | 0.1583 | 0.864 (0.513–1.455) | 0.5827 |
Pathologic stage (iii/i) | 2.676 (1.754–4.083) | 4.92E−06 | 1.794 (1.125–2.861) | 0.0141 |
Pathologic stage (iv/i) | 5.496 (1.695–17.821) | 0.0045 | 2.836 (0.818–9.833) | 0.1003 |
Notes.
Derived from risk score model based on the expression of prognostic lncRNAs.